FDA Panel Votes to Approve Pfizer’s Vaccine for Children

FDA Panel Votes to Approve Pfizer’s Vaccine for Children

The benefits of Pfizer’s COVID-19 vaccine for children ages 5 to 11 outweigh its risks, according to an independent panel of vaccine experts that advises the FDA. Read full article here

The benefits of Pfizer’s COVID-19 vaccine for children ages 5 to 11 outweigh its risks, according to an independent panel of vaccine experts that advises the FDA.

Read full article here

admin
ADMINISTRATOR
PROFILE

Posts Carousel

Leave a Comment

Your email address will not be published. Required fields are marked with *